Impaired nonhomologous end-joining in mismatch repair-deficient colon carcinomas

Area of Science:

• Molecular Biology
• Cancer Genetics
• DNA Repair Mechanisms

Background:

• Mismatch repair (MMR) deficiency is linked to frameshift mutations in genes like hRAD50 and hMRE11.
• The hRAD50-hMRE11-NBS1 complex is crucial for double-strand DNA break repair via homologous recombination and nonhomologous end-joining (NHEJ).

Purpose of the Study:

• To investigate the role of hRAD50 and hMRE11 gene alterations in MMR-deficient tumors.
• To analyze hRAD50 and hMRE11 protein expression and evaluate NHEJ activity in colon cancer cell lines with varying MMR status.

Main Methods:

• Analysis of hRAD50 and hMRE11 gene mutations and splicing variants in MMR-deficient and MMR-proficient colon cancer cell lines.
• Assessment of hRAD50 and hMRE11 mRNA and protein expression levels.
• Evaluation of nonhomologous end-joining (NHEJ) efficiency and sensitivity to gamma-irradiation.
• Functional studies using small interfering RNA (siRNA) to knock down hRAD50 and hMRE11 expression.

Main Results:

• Frameshift mutations in hRAD50 and mutant hMRE11 splicing variants were frequent in MMR-deficient cell lines.
• Decreased expression of hRAD50 and hMRE11 proteins was observed in MMR-deficient cell lines with these mutations.
• MMR-deficient cell lines with reduced hRAD50/hMRE11 expression exhibited increased sensitivity to gamma-irradiation and impaired NHEJ.
• Knockdown of hRAD50 and hMRE11 using siRNA confirmed their role in NHEJ impairment.

Conclusions:

• Alterations in hRAD50 and hMRE11 genes are associated with defective nonhomologous end-joining (NHEJ) in MMR-deficient tumors.
• Impaired NHEJ due to these mutations may contribute to chromosomal instability and tumor progression.
• Understanding these mechanisms could offer insights into targeted therapies for MMR-deficient cancers.